Top compounds associated with response to LYPLA2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.005
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.092 0.005
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.094 0.005
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.09 0.006
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.1 0.006
mRNA Gemcitabine gCSI pan-cancer AAC -0.16 0.006
mRNA Axitinib CTRPv2 pan-cancer AAC -0.092 0.007
mRNA KIN001-244 GDSC1000 pan-cancer AAC -0.085 0.007
mRNA GDC-0941 gCSI pan-cancer AAC -0.17 0.008
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.009
Download CSV